alpha hemolysin inhibitor (HZI)

N/A

Report date: 2025/03/14 16:54:05
NME

Base Information

Drug Namealpha hemolysin inhibitor (HZI)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha-hemolysin inhibitors
TargetsAlpha-hemolysin
Therapy Area/IndicationsMultidrug-Resistant InfectionPneumoniaStaphylococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHelmholtz Zentrum fur Infektionsforschung GmbH
China Registration ClassN/A

Develop Information

Active CompaniesHelmholtz Zentrum fur Infektionsforschung GmbHLead Discovery Center GmbH
Inactive CompaniesN/A
Active IndicationsMultidrug-Resistant InfectionPneumoniaStaphylococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A